Clinical trial

Lansoprazole Preventing Gastroduodenal Stress Ulcerations

NCT00220909 · Temple University, Other · Terminated

Key facts

NCT number NCT00220909
Title Lansoprazole Preventing Gastroduodenal Stress Ulcerations
Official title A Prospective, Randomized, Double-Blind Protocol to Compare the Efficacy of Lansoprazole to Ranitidine in Healing Pre-Existing and/or Preventing the Development of Gastroduodenal Stress Ulceration and Postoperative Bleeding in Patients Undergoing Elective Coronary Artery Bypass Graft or Cardiac…
Lead sponsor Temple University, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Patients Undergoing Elective Coronary Artery Bypass Graft
Intervention type Drug
Interventions Lansoprazole
Enrollment 40
Start date Sep 1, 2005
Completion Jan 1, 2006
First posted Sep 22, 2005
Last update posted Jan 11, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies